FDA Adverse Event Injury Summary report: N

SPIDER FX

MDR report key: 6043250 · Received October 20, 2016

Report

Report Number
2183870-2016-00646
Event Type
Injury
Date Received
October 20, 2016
Date of Event
May 26, 2016
Report Date
September 21, 2016
Manufacturer
COVIDIEN
Product Code
NTE
PMA / PMN Number
K111010
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AGE AT EVENT - AVERAGE AGE GENDER - GENDER - DATE OF EVENT - DATE OF PUBLICATION JAPAN RADIOLOGICAL SOCIETY 2016 JPN J RADIOL (2016) 34:523¿528 "PERIOPERATIVE AND FOLLOW-UP RESULTS IN CAROTID ARTERY STENTING WITH CONTRALATERAL CAROTID OCCLUSION" AHMET PEKER, MINE HAYRIYE SORGUN, CANAN TOGAY ISIKAY, ETHEM MURAT ARSAVA, MEHMET AKIF TOPCUOGLU, ANIL ARAT (B)(6). DOI 10.1007/S11604-016-0554-2. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ROUTINE PROCEDURE: OBTAINED ACCESS THROUGH THE PERCUTANEOUS FEMORAL ARTERY. CROSSED THE INTERNAL CAROTID ARTERY WITH THE EMBOLIC PROTECTION SYSTEM(TEN SPIDER FX DEVICES WERE USED DURING THE TREATMENT OF 26 PATIENTS.) DISTAL PROTECTION DEVICES WERE DEPLOYED BEYOND THE STENOSIS IN THE DISTAL SEGMENT OF THE NORMAL, STRAIGHT ICA. ANGIOPLASTY TYPICALLY PERFORMED TO PRE-DILATE THE LESION. A SELF-EXPANDING CLOSED-CELL STENT WAS THEN DEPLOYED. A SECOND STENT WAS DEPLOYED IF NEEDED. POST-DILATION WAS THEN PERFORMED WITH A BALLOON 20 MM IN LENGTH. IT IS REPORTED THAT 22 PATIENTS HAD A STROKE. CONTEXT OF STROKE UNKNOWN. ONE PATIENT WITH A POOR INITIAL NEUROLOGICAL STATUS HAS POST-PROCEDURE HYPERPERFUSION WITH SEIZURES BUT WITHOUT AN INTRACRANIAL BLEED. THE PATIENT WAS MANAGED MEDICALLY WITH INDUCED HYPOTENSION. CLOPIDOGREL WAS STOPPED AND THE PATIENT WAS DISCHARGED AT BASELINE NEUROLOGICAL STATUS AND PLACED ON ASPIRIN AND LOW MOLECULAR WEIGHT HEPARIN. THE PATIENT FAILED TO COMPLY WITH HIS MEDICATIONS AND PRESENTED WITH STENT OCCLUSION AFTER HIS DISCHARGE AND AFTER 30 DAYS. THERE WAS A DECLINE IN THE PATIENT'S MRS FROM 4 TO 5; OTHERWISE THERE WAS NO DECLINE IN MRS DURING THE POST-DISCHARGE FOLLOW-UP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
695123 SPIDER FX CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE NTE COVIDIEN

Patients

Seq Age Sex Outcome Treatment
1 65 YR Required Intervention